Gilead pulls back 'orphan drug' request for experimental COVID drug
March 25, 2020 at 14:40 PM EDT
The Foster City-based company had faced criticism from Sen. Bernie Sanders and others about the designation, which would carry tax benefits and expand exclusivity for its experimental COVID-19 drug.
